Sinoway Industrial Co., Ltd.

Dabigatran Etexilate 211915-06-9 Dabigatran Etexilate 211915-06-9

Dabigatran Etexilate 211915-06-9
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of  Dabigatran etexilate :

Name

Dabigatran etexilate

Alias

BIBR-1048(Dabigatran etexilate);N-[2-[4-[N-(Hexyloxycarbonyl)aMidino]phenylaMinoMethyl]-1-Methyl-1H-benziMidazol-5-ylcarbonyl]-N-(2-;BIBR 1048;BIBR-1048;Prazaxa;N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMidino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridyl-beta-alanine,ethyl ester;Pradaxa (dabigatran);Dabigatran Etexilate (free base)

CAS NO.

211915-06-9

Molecular Formula

C34H41N7O5

Molecular Weight

627.74

Brief Introduction

Dabigatran etexilate is a novel oral anticoagulant drug that exerts anticoagulant activity by directly inhibiting thrombin.


Use of  Dabigatran etexilate:

Dabigatran Etexilate is an oral anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in some cases, it offers an alternative to warfarin as the preferred orally administered anticoagulant ("blood thinner") since it does not require blood tests for the international normalized ratio (INR) monitoring while offering similar results in terms of efficacy.

  • Solifenacin succinate 242478-38-2
    Basic information of Solifenacin succinate :NameSolifenacin succinateAlias1-azabicyclo[2.2.2]octan-8-yl (1s)-1-phenyl-3,4-dihydro-1h-isoquinoline-2-carboxylate butanedioic acid;vesicare;solifenacin s... Solifenacin succinate 242478-38-2
  • Oxaliplatin 61825-94-3
    Basic information of Oxaliplatin :Name OxaliplatinAliastrans-l-diaminocyclohexane oxalatoplatinum; oxalato(1r,2r-cyclohexanediammine)platinum(ii); oxalatoplatin; oxalatoplatinumCAS NO.61825-94-3Molecu... Oxaliplatin 61825-94-3
  • Acarbose 56180-94-0
    Basic information of Acarbose tabletsCAS No.: 56180-94-0Other Names: AcarboseMolecular Formula: C25H43NO18Molecular Weight: 645.6Grade Standard: Medicine GradePurity: 98.5% upUsesAcarbose is used fo... Acarbose 56180-94-0
  • Sofosbuvir 1190307-88-0
    Basic information :Other name: GS-7977;N-[[P(S),2'R]-2'-Deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine 1-methylethyl ester;PSI 7977;sofosbuvir;GS-7977/sofosbuvir;sofosbuvir, PSI7977;(S)-i... Sofosbuvir 1190307-88-0

MORE_DETAIL Dabigatran Etexilate 211915-06-9

Basic information of  Dabigatran etexilate :

Name

Dabigatran etexilate

Alias

BIBR-1048(Dabigatran etexilate);N-[2-[4-[N-(Hexyloxycarbonyl)aMidino]phenylaMinoMethyl]-1-Methyl-1H-benziMidazol-5-ylcarbonyl]-N-(2-;BIBR 1048;BIBR-1048;Prazaxa;N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMidino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridyl-beta-alanine,ethyl ester;Pradaxa (dabigatran);Dabigatran Etexilate (free base)

CAS NO.

211915-06-9

Molecular Formula

C34H41N7O5

Molecular Weight

627.74

Brief Introduction

Dabigatran etexilate is a novel oral anticoagulant drug that exerts anticoagulant activity by directly inhibiting thrombin.


Use of  Dabigatran etexilate:

Dabigatran Etexilate is an oral anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in some cases, it offers an alternative to warfarin as the preferred orally administered anticoagulant ("blood thinner") since it does not require blood tests for the international normalized ratio (INR) monitoring while offering similar results in terms of efficacy.
Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//